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Versus Objectively Measured Functional
Capacity in Patients With Heart Failure
Results From the TIME-CHF
(Trial of Intensified Versus Standard Medical
Therapy in Elderly Patients With Congestive Heart Failure)
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tTo the Editor: A central aspect of quality of life in patients with
heart failure (HF) is their ability to perform daily activities, which
may be quantified by the Duke Activity Status Index (DASI)
questionnaire (1). Lower DASI scores were shown to be related
independently to event-free survival in patients after hospitaliza-
tion for HF, whereas the 6-min walk distance (6MWD) assess-
ment was not retained in multivariate analysis (2). These data
suggest that a HF patient’s subjective perception may be of greater
clinical importance than an objective measure of exercise capacity
would be. However, hospitalized patients may have difficulties
assessing their daily limitations accurately, as well as performing
exercise tests optimally. Moreover, DASI score and 6MWD may
change over time. Therefore, we evaluated to what extent DASI
score and 6MWD change over 1 year and whether such changes
might affect prognosis in patients with chronic HF. We hypoth-
esized that an increase in DASI score and an increase in 6MWD
would be accompanied with reduced risk.
Patients from the TIME-CHF (Trial of Intensified Versus
Standard Medical Therapy in Elderly Patients With Congestive
Heart Failure) who completed the evaluation at baseline and after
1 year were analyzed. TIME-CHF has been described in detail
elsewhere (3). In brief, the DASI (points), a simple 12-item
patient-reported questionnaire that estimates functional capabili-
ties based on daily activities was used (1). DASI and 6MWD were
done on the same day. Patients were divided below and above the
median change in DASI or 6MWD. The primary endpoint of
the present analysis was all-cause mortality; secondary endpoints
were HF hospitalization and all-cause hospitalization up to 4 years
after 1-year assessment. Results are presented as mean  SD or
edian (interquartile range [IQR]). Between-group comparisons
ere performed using Student t, Mann-Whitney U, or Pearson
hi-squared test, as appropriate. Kaplan-Meier curves were used
or calculating time-dependent occurrences of events. We esti-
ated hazard ratios (HR) by Cox proportional hazards model. A
-sided p value of 0.05 was considered statistically significant.
ll calculations were performed with the use of the SPSS (version
9.0, SPSS Inc., Chicago, Illinois).
In 309 patients (35.3% women), complete data were available.
t baseline, mean age was 76  8 years, ejection fraction was
4  12%, and body mass index was 25.6  4.2 kg/m2. Coronary
rtery disease was the cause of HF in 56% of the patients. At daseline, patients had low median DASI scores (10.0 [IQR: 4.5 to
9.0] points). Moreover, baseline median 6MWD (293 [IQR: 203
o 377] m) was poor, as healthy elderly walk on average 600
eters (4). One year after initial evaluation, the DASI improved
y a median of 5.5 (IQR: 0 to 15.2) points, whereas the 6MWD
mproved by a median of 40 (IQR: –10 to 103) m.
During follow-up (median: 1,071 days; IQR: 769 to 1,375
ays), 59 patients passed away, and 165 patients were hospitalized
t least once, of which 66 admissions were HF related. Absolute
umbers of events per strata are reported in Table 1.
Patients with change in DASI scores below median had a worse
urvival than did patients with a change above median (HR: 2.08,
5% confidence interval [CI]: 1.25 to 3.47, p 0.0051) (Fig. 1A).
ack of an increase in 6MWD by 40 m did not affect all-cause
ortality significantly (HR: 1.35, 95% CI: 0.81 to 2.25, p  0.26)
(Fig. 1B).
Lack of increasing DASI score of5.5 points did not affect HF
hospitalization-free survival significantly (HR: 1.39, 95% CI: 0.86
to 2.26, p  0.18) (Fig. 1C), but all-cause hospitalization-free
survival (HR: 1.53, 95% CI: 1.12 to 2.08, p  0.0072) (Fig. 1E).
Lack of increasing 6MWD by 40 m did not affect HF
hospitalization-free survival significantly (HR: 1.40, 95% CI: 0.86
to 2.26, p  0.18) (Fig. 1D), but all-cause hospitalization-free
survival (HR: 1.54, 95% CI: 1.14 to 2.10, p  0.0056) (Fig. 1F).
These findings suggest that improved self-reported physical
apacity after 1 year seems to be associated with a better prognosis
n patients with HF, whereas objective measures of improvement
n physical capacity seem to have a limited value. Thus, the
atient’s ability to estimate his own daily “working” capacity seems
o carry a higher prognostic value than that estimated from repeat
Changes in DASI Score and 6MWDTable 1 Changes in DASI Score and 6MWD
Change in DASI Score Change in 6MWD
< Median > Median < Median > Median
Deaths, n 39 20 34 25
HF hospitalization, n 36 30 39 27
AC hospitalization, n 91 74 98 67AC  all-cause; DASI  Duke Activity Status Index; HF  heart failure; 6MWD  6-min walk
istance.
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likely in HF patients with lower peak aerobic capacity, 6MWD is
no surrogate for peak aerobic capacity (5). Therefore, 1-year
changes in peak aerobic capacity may still have a prognostic value
Figure 1 Kaplan-Meier Curves for Survival, HF Hospitalization-Free
Survival, and All-Cause Hospitalization-Free Surival
Kaplan-Meier curves for survival (A, B), heart failure (HF) hospitalization-free
survival (C, D), and all-cause (AC) hospitalization-free survival (E, F) after strati-
fication for change in Duke Activity Status Index (above median, blue line;
below median, red line) (A, C, E) and for change in 6-min walk distance (above
median, blue line; below median, red line) (B, D, F).in patients with HF.Although the current findings are hypothesis-generating rather
than definitive and require further study, it seems reasonable to
recommend estimating self-reported physical capacity by using the
DASI in daily clinical practice. It is a short, simple, and readily
available office screening tool. In HF, it allows individual risk
assessment. Current findings stress the importance to increase the
levels of regular daily activities in patients with HF, as this is
associated with improved prognosis and lower healthcare costs.
This is in line with data from the Copenhagen City Heart Study
in healthy subjects. Those who were able to adopt a higher degree
of self-reported physical activity had lower mortality rates during
follow-up (6).
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